Edwards Lifesciences Corp - Asset Resilience Ratio

Latest as of March 2026: 9.20%

Edwards Lifesciences Corp (EW) has an Asset Resilience Ratio of 9.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Edwards Lifesciences Corp to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$1.23 Billion

Cash + Short-term Investments

Total Assets

$13.32 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Edwards Lifesciences Corp's Asset Resilience Ratio has changed over time. See how leveraged is Edwards Lifesciences Corp's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Edwards Lifesciences Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EW market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.23 Billion	9.2%
Total Liquid Assets	$1.23 Billion	9.20%

Asset Resilience Insights

Limited Liquidity: Edwards Lifesciences Corp maintains only 9.20% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Edwards Lifesciences Corp Industry Peers by Asset Resilience Ratio

Compare Edwards Lifesciences Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
GN Store Nord CO:GN	Medical Devices	-4.56%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Shandong Weigao Orthopaedic Device Co. Ltd. A SHG:688161	Medical Devices	6.28%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%

Annual Asset Resilience Ratio for Edwards Lifesciences Corp (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Edwards Lifesciences Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	30.86%	$4.23 Billion	$13.70 Billion	+0.40pp
2024-12-31	30.45%	$3.98 Billion	$13.06 Billion	+12.89pp
2023-12-31	17.56%	$1.64 Billion	$9.36 Billion	+2.91pp
2022-12-31	14.66%	$1.22 Billion	$8.29 Billion	-2.60pp
2021-12-31	17.25%	$1.47 Billion	$8.50 Billion	-2.13pp
2020-12-31	19.38%	$1.40 Billion	$7.24 Billion	-4.00pp
2019-12-31	23.38%	$1.52 Billion	$6.49 Billion	+5.41pp
2018-12-31	17.97%	$956.50 Million	$5.32 Billion	-5.51pp
2017-12-31	23.48%	$1.34 Billion	$5.70 Billion	-4.70pp
2016-12-31	28.18%	$1.27 Billion	$4.51 Billion	+15.71pp
2015-12-31	12.47%	$506.30 Million	$4.06 Billion	-9.80pp
2014-12-31	22.27%	$785.00 Million	$3.52 Billion	+3.32pp
2013-12-31	18.96%	$516.50 Million	$2.72 Billion	+9.48pp
2012-12-31	9.48%	$210.50 Million	$2.22 Billion	-4.63pp
2011-12-31	14.10%	$279.30 Million	$1.98 Billion	--
2010-12-31	0.00%	$0.00	$1.77 Billion	--
2008-12-31	0.58%	$8.10 Million	$1.40 Billion	-3.09pp
2007-12-31	3.67%	$49.40 Million	$1.35 Billion	--

pp = percentage points

About Edwards Lifesciences Corp

NYSE:EW USA Medical Devices

Market Cap

$49.68 Billion

Market Cap Rank

#550 Global

#273 in USA

Share Price

$86.28

Change (1 day)

+1.37%

52-Week Range

$72.65 - $88.16

All Time High

$130.68